$ZVRA reports third quarter 2026 financial
results and provides a
corporate update.
Join our LIVE webcast TODAY at 4:30 p.m. ET: event.on24.com/wcc/r/5509988…
For more, find the full release here: investors.zevra.com/news-rel…
#RareDiseases
#InvestorRelations
#IR
Honored to attend the #PrixGalien Gala & proud to be nominated for the Innovative Rare Disease Product Award.
Most importantly, we celebrate the patients & families at the heart of this work & remain committed to redefining what’s possible for people living with rare diseases.
This October, our teams connected with researchers, clinicians & colleagues at 3 scientific meetings.
As we close out #NPCAwarenessMonth, we remain committed to listening, learning & keeping patients & families at the center of our work.
#NPC #RareDisease
$ZVRA will report third quarter 2026 financial results & provide a corporate update on Tuesday, November 3, 2026, with a live webcast at 4:30 p.m. ET.
For registration details, see the release: investors.zevra.com/news-rel…
Zevra is honored to be nominated in the Prix Galien USA Best Product for Rare/Orphan Disease category!
Join our CEO Neil McFarlane and fellow nominees for a panel discussion on October 26 at 12 p.m. ET.
Register here: us06web.zoom.us/webinar/regi…
#PrixGalien #RareDisease
On #NPCAwarenessDay, we stand with the individuals and families living with Niemann-Pick disease type C.
We recognize their strength, resilience and voices, and remain committed to listening, learning and making a meaningful difference for the NPC community.
We're excited to be in Montréal for the Child Neurology Society (CNS) and the American Society of Human Genetics (ASHG) annual meetings.
Attending? Stop by booth #406 at CNS or booth #1302 at ASHG to connect with our team.
#CNS #ASHG #RareDisease
Patients and families are at the heart of everything we do.
On October 15 at 7pm, join the global Wave of Light in honor of the NPC community. Light a candle and share a photo or video using #LightForNiemannPick.
#RareDisease
We’re pleased to share that positive data in Niemann-Pick disease type C (NPC) will be featured in a podium presentation at #CNS.
We’re grateful to the researchers & clinicians advancing understanding of NPC & to the community that inspires this work.
Research moves forward because patients, families, investigators, and advocates come together.
The Phase 3 DiSCOVER study is evaluating an investigational treatment for vascular Ehlers-Danlos syndrome (VEDS).
Learn more: discoverceliprolol.com/
#VEDS #ClinicalTrials #RareDisease
Team Zevra came together in Newport for our annual all-company meeting, connecting, collaborating, sharing big ideas & getting energized for what’s ahead.
We left feeling inspired & ready to bring our mission to life for the patients & families who motivate us every day.
Behind every rare disease journey is often a caregiver providing strength, advocacy, and unwavering support.
To all caregivers: your dedication makes a profound difference.
#Caregivers #RareDisease #PatientAdvocacy #CaregiverSupport #RareDiseaseCommunity
Thanks to the Termeer Institute for hosting a great networking session & panel discussion on Building Impactful Teams & Culture. We were proud to have our Chief People Officer, Alison Peters share insights on building strong teams & fostering a culture where people can thrive.
Our President & CEO will present at 2 upcoming investor conferences:
Morgan Stanley Annual Global Healthcare Conference
🗓️ Sept 14, 2026
🕔 5:35 pm ET
H.C. Wainwright Annual Global Investment Conference
🗓️ September 15, 2026
🕙 10 am ET
Register here: investors.zevra.com/events-a…
September is #NewbornScreeningAwarenessMonth.
At Zevra, we recognize the difference earlier diagnosis can make for families affected by NPC & other rare diseases.
We’re proud to support efforts to expand newborn screening & help more families find answers sooner.
#RareDisease
Join our President and CEO, Neil McFarlane, as he shares company updates at the Cantor Global Healthcare Conference.
🗓️ September 9, 2026
🕘 9:10 a.m. ET
Register for the webcast presentation here: investors.zevra.com/events-a…
This Labor Day, we're grateful for the healthcare professionals, researchers, caregivers, advocates, and employees whose dedication helps advance care for people living with rare diseases.
Thank you for all you do. Wishing everyone a safe and restful holiday.
#LaborDay
At Zevra, we're united by one purpose: improving the lives of people living with rare diseases.
Every role, every project, and every milestone starts with patients and families.
#RareDisease #PatientCentricity
Thank you to the SSIEM attendees for an engaging and impactful meeting focused on advancing care for people living with rare metabolic diseases, including Niemann-Pick disease type C (NPC).
#SSIEM2026 #RareDisease #NPC
We’re presenting two posters featuring new real-world data on arimoclomol in Niemann-Pick disease type C (NPC) during a dedicated poster walk on Wed. August 26, from 5:30–6:30 pm CEST at SSIEM 2026.
Read the press release: investors.zevra.com/news-rel…
#SSIEM2026 #RareDisease #NPC
